Risk Factors Update Summary
- Potential termination of state-based licenses for Affiliated Pharmacies could materially impact operations.
- Revenue growth from $271 million in 2022 to $526 million in 2023 is significant.
- Increase in full-time employees from 398 in 2021 to 1,046 in 2023 is substantial.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1773751&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.